Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

To see complete record on, please visit this link

Id: NCT02061293

Organisation Name: NYU Langone Health

Overal Status: Completed

Start Date: June 2014

Last Update: November 8, 2022

Lead Sponsor: NYU Langone Health

Brief Summary: Several lines of evidence suggest that classic hallucinogens such as psilocybin can facilitate behavior change in addictions such as alcohol dependence. The proposed investigation is a multi-site, double-blind active-controlled trial (n = 180, 90 per group) contrasting the acute and persisting effects of psilocybin to those of diphenhydramine in the context of outpatient alcoholism treatment.

  • Alcohol Dependence

Total execution time in seconds: 0.26587700843811